Evaluation of nitric oxide metabolites in a group of subjects with metabolic syndrome

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 6, Issue 3, 2012, Pages 132-135

  Caimi, Gregorio ^a   Hopps, Eugenia ^a   Montana, Maria ^a   Noto, Davide ^a   Canino, Baldassare ^a   Lo Presti, Rosalia ^a   Averna, Maurizio R ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Metabolic syndrome; Nitric oxide metabolites; Oxidative stress

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; NITRIC OXIDE; NITRITE; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK ASSESSMENT;

BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; INFLAMMATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES; OXIDATIVE STRESS;

EID: 84869505588     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2012.09.012     Document Type: Article

References (42)

1. S.Z. Asl, A. Ghasemi, and F. Azizi Serum nitric oxide metabolites in subjects with metabolic syndrome Clinical Biochemistry 41 2008 1342 1347
2. M.C. Stuhlinger, F. Abbasi, J.W. Chu, C. Lamendola, T.L. McLaughlin, and J.P. Cooke Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor The Journal of the American Medical Association 287 11 2002 1420 1426
3. P. Chedraui, G.S. Escobar, C. Ramírez, F.R. Pérez- López, L. Hidalgo, and P. Mannella Nitric oxide and pro-inflammatory cytokine serum levels in postmenopausal women with the metabolic syndrome Gynecological Endocrinology April 2012
4. K.G. Alberti, P. Zimmet, and J. Shaw Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation Diabetic Medicine 23 2006 469 480
5. R.W. Nims, J.F. Darbyshire, J.E. Saavedra, D. Christodoulou, I. Hanbauer, and G.W. Cox Colorimetric methods for the determination of nitric oxide concentration in neutral aqueous solutions Methods 7 1995 48 54
6. A. Aydin, H. Orhan, A. Sayal, M. Ozata, G. Sahin, and A. Işimer Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control Clinical Biochemistry 34 2001 65 70
7. S. Ozden, S. Tatlipinar, N. Bicer, V. Yaylali, C. Yildirim, and D. Ozbay Basal serum nitric oxide levels in patients with type 2 diabetes mellitus and different stages of retinopathy Canadian Journal of Ophthalmology 38 2003 393 396
8. M. Olszanecka-Glinianowicz, B. Zahorska-Markiewicz, J. Janowska, and A. Zurakowski Serum concentration of nitric oxide, tumor necrosis factor (TNF)-α and TNF soluble receptors in women overweight and obesity Metabolism: Clinical and Experimental 10 2004 1268 1273
9. W.Y. Chien, K.D. Yang, H.L. Eng, Y.H. Hu, P.Y. Lee, and S.T. Wang Increased plasma concentration of nitric oxide in type 2 diabetes but not in nondiabetic individuals with insulin resistance Diabetes and Metabolism 31 2005 63 68
10. F.O. Pereira, T.S. Frode, and Y.S. Medeiros Evaluation of tumor necrosis alpha, interleukin-2, soluble receptor, nitric oxide metabolites, and lipid as inflammatory markers in type 2 diabetes mellitus Mediators of Inflammation 2006 1 2006 39062
11. H. Higashino, H. Miya, H. Mukai, and Y. Miya Serum nitric oxide metabolite (NOx) levels in hypertensive patients at rest: a comparison of age, gender, blood pressure and complications using normotensive controls Clinical and Experimental Pharmacology and Physiology 34 2007 725 731
12. H. Higashino, M. Tabuchi, S. Yamagata, T. Kurita, H. Miya, and H. Mukai Serum nitric oxide metabolite levels in groups of patients with various diseases in comparison of healthy control subjects Journal of Medical Sciences 10 2010 1 11
13. S.M. Ouvina, R.D. La Greca, N.L. Zanaro, L. Palmer, and B. Sassetti Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients Thrombosis Research 102 2001 107 114
14. I. Zavaroni, D. Ardigo, P.C. Rossi, A. Zuccarelli, E. Pacetti, and L. Monti Relationship between plasma nitric oxide concentration and insulin resistance in essential hypertension American Journal of Hypertension 17 2004 549 552
15. G. Caimi, G. Mulè, E. Hopps, C. Carollo, and R. Lo Presti Nitric oxide metabolites and oxidative stress in mild essential hypertension Clinical Hemorheology and Microcirculation 46 2010 321 325
16. S. Moncada, R.M.J. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology and pharmacology Pharmacological Reviews 43 1991 109 142
17. U. Forstermann, H. Kleinert, I. Gath, P. Schwarz, E.I. Closs, and N.J. Dun Expression and expressional control of nitric oxide synthases in various cell types Advances in Pharmacology 34 1995 171 186
18. J.B. Weinberg Nitric oxide production and nitric oxide syntases type 2 expression by human mononuclear phagocytes - a review Molecular Medicine 4 1998 557 591
19. J. Ueyama, T. Kondo, R. Imai, A. Kimata, K. Yamamoto, and K. Suzuki Association of serum NO(x) level with clustering of metabolic syndrome components in middle-aged and elderly general populations in Japan Environmental Health and Preventive Medicine 13 1 2008 36 42
20. L. Di Renzo, F. Galvano, C. Orlandi, A. Bianchi, C. Di Giacomo, and L. La Fauci Oxidative stress in normal-weight obese syndrome Obesity 18 2010 2125 2130
21. R.G. Garcia, M. Perez, R. Maas, E. Schwedhelm, R.H. Bögerc, and P. López-Jaramillo Plasma concentrations of asymmetric dimethylarginine (ADMA) in metabolic syndrome International Journal of Cardiology 122 2007 176 178
22. R.H. Böger, S.M. Bode-Böger, A. Szuba, P.S. Tsao, J.R. Chan, and O. Tangphao Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia Circulation 98 18 1998 1842 1847
23. R.H. Boger Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, explains the "l-arginine paradox" and acts as a novel cardiovascular risk factor Journal of Nutrition 134 2004 2842S 2847S
24. M. Siervo, and L.J.C. Bluck In vivo nitric oxide synthesis, insulin sensitivity, and asymmetric dimethylarginine in obese subjects without and with metabolic syndrome Metabolism: Clinical and Experimental 61 5 2012 680 688
25. D. Pitocco, F. Zaccardi, E. Di Stasio, F. Romitelli, F. Martini, and G. Luca Scaglione Role of asymmetric-dimethyl-l-arginine (ADMA) and nitrite/nitrate (NOx) in the pathogenesis of oxidative stress in female subjects with uncomplicated type 1 diabetes mellitus Diabetes Research and Clinical Practice 86 2009 173 176
26. T.M. Millar, C.R. Stevens, N. Benjamin, R. Eisenthal, R. Harrison, and D.R. Blake Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions FEBS Letters 427 1998 225 228
27. A. Modin, H. Björne, M. Herulf, K. Alving, E. Weitzberg, and J.O. Lundberg Nitrite-derived nitric oxide: a possible mediator of 'acidic-metabolic' vasodilation Acta Physiologica Scandinavica 171 2001 9 16
28. K. Cosby, K.S. Partovi, J.H. Crawford, R.P. Patel, C.D. Reiter, and S. Martyr Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation Nature Medicine 9 12 2003 1498 1505
29. J.O. Lundberg, and M. Govoni Inorganic nitrate is a possible source for systemic generation of nitric oxide Free Radical Biology and Medicine 37 2004 395 400
30. J.E. Ogden, and P.K. Moore Inhibition of nitric oxide synthase-potential for a novel class of therapeutic agent? Trends in Biotechnology 13 1995 70 78
31. Z.Q. Liu, S.M. Wildurth, and H.H. Zhou Specificity of inducible nitric-oxide synthase inhibitors: prospects for their clinical therapy Acta Pharmacologica 20 1999 1052 1056
32. M.J. Kim, G.R. Ryu, J.H. Kang, S.S. Sim, D.S. Min, and D.J. Rhie Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation Biochemical Pharmacology 68 9 2004 1775 1785
33. J.M. Cho, S.Y. Chang, D.B. Kim, P.W. Needs, Y.H. Jo, and M.J. Kim Effects of physiological quercetin metabolites on interleukin-1β-induced inducible NOS expression The Journal of Nutritional Biochemistry 23 11 2012 1394 1402
34. K. Tsuchiya, H. Sakai, N. Suzuki, F. Iwashima, T. Yoshimoto, M. Shichiri, and Y. Hirata Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice Endocrinology 148 2007 4548 4556
35. B.T. Noronha, J.M. Li, S.B. Wheatcroft, A.M. Shah, and M.T. Kearney Inducible nitric oxide synthase has divergent effects on vascular and metabolic function in obesity Diabetes 54 2005 1082 1089
36. H.N. Cha, Y.W. Kim, J.Y. Kim, Y.D. Kim, I.H. Song, K.N. Min, and S.Y. Park Lack of inducible nitric oxide synthase does not prevent aging-associated insulin resistance Experimental Gerontology 45 9 2010 711 718
37. M. Toprakçi, D. Ozmen, I. Mutaf, N. Turgan, Z. Parildar, and S. Habif Age-associated changes in nitric oxide metabolites nitrite and nitrate International Journal of Clinical and Laboratory Research 30 2 2000 83 85
38. A. Ghasemi, S. Zahedi Asl, Y. Mehrabi, N. Saadat, and F. Azizi Serum nitric oxide metabolite levels in a general healthy population: relation to sex and age Life Sciences 83 9-10 2008 326 331
39. R. Li, D. Lyn, R. Lapu-Bula, A. Oduwole, P. Igho-Pemu, and B. Lankford Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function, and blood pressure in African Americans American Journal of Hypertension 17 7 2004 560 567
40. J.W. Choi Enhanced nitric oxide production is closely associated with serum lipid concentrations in adolescents Clinica Chimica Acta 347 2004 151 156
41. T. Hayashi, H. Nomura, M. Osawa, J. Funami, A. Miyazaki, and A. Iguchi Nitric oxide metabolites are associated with survival in older patients Journal of the American Geriatrics Society 55 2007 1389 1403
42. M. Osawa, T. Hayashi, H. Nomura, J. Funami, A. Miyazaki, and L.J. Ignarro Nitric oxide (NO) is a new clinical biomarker of survival in the elderly patients and its efficacy might be nearly equal to albumin Nitric Oxide 16 2007 157 163